Hims & Hers

News

Hims & Hers launches weight-loss business in UK

Hims & Hers has launched its direct-to-consumer weight-loss therapy channel in the UK, offering Wegovy, Mounjaro, and OTC option Orlos.

News

Novo Nordisk's fling with Hims & Hers ends in a bust-up

The alliance between Novo Nordisk and telehealth firm Hims & Hers for the distribution of GLP-1 agonist weight-loss therapies has ended in acrimony.

News

Hims & Hers buys Zava to form European beachhead

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe.

News

Stethoscope on a tablet with digital globe overlain

Novo Nordisk unleashes Wegovy telehealth blitz

Novo Nordisk has enlisted the aid of major telehealth companies as it tries to dominate the self-pay market for obesity drugs in the US.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

Hims & Hers launches weight-loss business in UK

Novo Nordisk's fling with Hims & Hers ends in a bust-up

Hims & Hers buys Zava to form European beachhead

Novo Nordisk unleashes Wegovy telehealth blitz

Compounders cast adrift after semaglutide shortage ends

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Ambros' $125m for pain disorder drug, and other financings

How to meet your physicians where they are online

Hims & Hers

Editor's Picks